BAFNA PHARMA Fact Sheet, BAFNA PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAFNA PHARMA Fact Sheet    (BAFNPH)


FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit


Here is the latest financial fact sheet of BAFNA PHARMA. For more details, see the BAFNA PHARMA quarterly results and BAFNA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

BAFNA PHARMA Price History

Price Rs 121.0
Mkt Cap Rs m 2,862
Vol '000 0.5
P/E X 35.8
P/CF X 27.8
EPS (TTM) Rs 3.4
% ch % 0.5
No. of shares m 23.66
% ch week % -4.3
% ch 1-mth % -4.5
% ch 12-mth % 62.3
52 week H/L Rs 196.0/78.3
(As on Nov 30, 2021 02:58:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BAFNA PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
BAFNA PHARMA EQUITY SHARE DATA
High Rs36323011196 
Low Rs2620959 
Sales per share (Unadj.) Rs34.119.918.4179.230.1 
Earnings per share (Unadj.) Rs-10.4-7.1-8.2-7.92.5 
Diluted earnings per shareRs-8.2-7.1-8.2-0.82.5 
Cash flow per share (Unadj.) Rs-8.2-5.5-6.75.84.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs20.716.08.1-17.924.0 
Adj. book value per shareRs16.316.08.1-1.824.0 
Shares outstanding (eoy) m18.6623.6623.662.3723.66 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.91.31.103.4 
Avg P/E ratio x-3.0-3.7-2.4-1.041.7 
P/CF ratio (eoy) x-3.8-4.8-2.91.323.6 
Price / Book Value ratio x1.51.62.4-0.44.3 
Dividend payout %00000 
Avg Mkt Cap Rs m579620462182,428 
No. of employees `000NANANANANA 
Total wages/salary Rs m687590103120 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
BAFNA PHARMA INCOME DATA
Net Sales Rs m636472436425712 
Other income Rs m11313437 
Total revenues Rs m647785440427720 
Gross profit Rs m-58-351-13112103 
Depreciation Rs m4240353345 
Interest Rs m115692117 
Profit before tax Rs m-204-147-183-1958 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-9221100 
Profit after tax Rs m-195-169-194-1958 
Gross profit margin %-9.1-74.5-30.02.914.5 
Effective tax rate %4.4-14.9-5.800 
Net profit margin %-30.6-35.8-44.4-4.48.2 
BAFNA PHARMA BALANCE SHEET DATA
Current assets Rs m772487485361497 
Current liabilities Rs m815598708171243 
Net working cap to sales %-6.7-23.5-51.244.735.6 
Current ratio x0.90.80.72.12.0 
Inventory Days Days30134628400 
Debtors Days Days30918820852490 
Net fixed assets Rs m1,011896710352368 
Share capital Rs m18723723724237 
"Free" reserves Rs m200143-46-66331 
Net worth Rs m387379191-42568 
Long term debt Rs m3902322303053 
Total assets Rs m1,7831,3841,195713865 
Interest coverage x-0.8-1.1-7.6-18.68.9 
Debt to equity ratio x1.00.61.2-0.70.1 
Sales to assets ratio x0.40.30.40.60.8 
Return on assets %-4.5-7.2-14.4-2.57.6 
Return on equity %-50.3-44.6-101.644.410.3 
Return on capital %-11.4-12.7-38.4146.110.6 
Exports to sales %00000 
Imports to sales %3.48.75.05.55.9 
Exports (fob) Rs m00000 
Imports (cif) Rs m2141222442 
Fx inflow Rs m235207260250347 
Fx outflow Rs m2141222442 
Net fx Rs m214166239226305 
BAFNA PHARMA CASH FLOW
From Operations Rs m -9 -70 -18 -343 -136 
From Investments Rs m -54 380 154 328 -53 
From Financial Activity Rs m 63 -306 -138 73 123 
Net Cashflow Rs m -1 3 -2 58 -67 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 90.4%
Institution 0.0%
Non-Institution 9.6%
Total 100.0%
Free Float 9.6%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Bafna Towers, New No 68 Old No.299, Thambu Chetty Street, Chennai - 600001
E-MAIL info@bafnapharma.com WEB www.bafnapharma.com
TEL 044- 25267517/25270992/42677555 FAX 044- 25231264
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Cameo Corporate Services Ltd, Subramanian Buildings No 1, Club House Road
YEAR OF INC: 1995 BSE CODE: 532989 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   BLISS GVS PHARMA  ASHRAM ONLINE  SYNGENE INTERNATIONAL  DR HABEEBULLAH LIFE SCIENCES  ANUH PHARMA  

Compare BAFNA PHARMA With:   BLISS GVS PHARMA  ASHRAM ONLINE  SYNGENE INTERNATIONAL  DR HABEEBULLAH LIFE SCIENCES  ANUH PHARMA  




Today's Market

Sensex Zooms 600 Points, Nifty Tops 17,250; Bajaj Finserv & Tech Mahindra Top Gainers(10:30 am)

Asian share markets are trading in positive territory as investors became cautiously optimistic the new Omicron variant might not cause a widespread global economic.

Views on news

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BAFNA PHARMA

  • Track your investment in BAFNA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BAFNA PHARMA

BAFNA PHARMA 8-QTR ANALYSIS

COMPARE BAFNA PHARMA WITH

MARKET STATS